Susan G. Kornstein

16.7k total citations · 3 hit papers
159 papers, 10.8k citations indexed

About

Susan G. Kornstein is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Susan G. Kornstein has authored 159 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Pharmacology, 59 papers in Experimental and Cognitive Psychology and 40 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Susan G. Kornstein's work include Treatment of Major Depression (88 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (41 papers) and Mental Health Research Topics (39 papers). Susan G. Kornstein is often cited by papers focused on Treatment of Major Depression (88 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (41 papers) and Mental Health Research Topics (39 papers). Susan G. Kornstein collaborates with scholars based in United States, Canada and Singapore. Susan G. Kornstein's co-authors include A. John Rush, Michael E. Thase, Madhukar H. Trivedi, Martin B. Keller, Daniel N. Klein, Philip T. Ninan, John C. Markowitz, James H. Kocsis, Rachel Manber and Bruce A. Arnow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Stroke.

In The Last Decade

Susan G. Kornstein

153 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003 3.0k citations A. John Rush, Madhukar H. Trivedi et al. profile →
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

2003 569 citations Michael E. Thase, Daniel N. Klein et al. profile →
Gender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression

2000 509 citations Susan G. Kornstein, Alan F. Schatzberg et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan G. Kornstein United States	47	4.1k	3.4k	2.8k	2.6k	1.8k	159	10.8k
Jonathan E. Alpert United States	66	4.5k 1.1×	3.3k 1.0×	3.0k 1.1×	3.7k 1.4×	1.5k 0.9×	233	12.7k
James F. Luther United States	41	5.3k 1.3×	2.9k 0.9×	2.0k 0.7×	3.4k 1.3×	1.7k 1.0×	116	11.4k
Arun Ravindran Canada	53	3.3k 0.8×	1.9k 0.6×	2.6k 0.9×	3.8k 1.5×	903 0.5×	192	10.8k
Richard C. Shelton United States	57	4.4k 1.1×	3.6k 1.1×	3.1k 1.1×	3.5k 1.4×	748 0.4×	244	13.5k
Aart H. Schene Netherlands	67	2.1k 0.5×	2.7k 0.8×	4.5k 1.6×	4.6k 1.8×	1.1k 0.6×	332	15.9k
Thomas Carmody United States	50	3.0k 0.7×	3.0k 0.9×	2.9k 1.0×	3.9k 1.5×	1.0k 0.6×	209	11.5k
Julien Mendlewicz Belgium	59	3.0k 0.7×	2.6k 0.8×	2.5k 0.9×	4.7k 1.8×	559 0.3×	386	13.1k
G.K. Balasubramani United States	41	3.7k 0.9×	2.5k 0.8×	1.4k 0.5×	1.9k 0.7×	581 0.3×	143	8.8k
James H. Kocsis United States	55	3.8k 0.9×	3.5k 1.1×	3.0k 1.1×	3.9k 1.5×	575 0.3×	178	10.4k
Rudolf Uher Canada	66	2.5k 0.6×	3.0k 0.9×	7.2k 2.6×	4.1k 1.6×	1.9k 1.1×	248	16.9k

Countries citing papers authored by Susan G. Kornstein

Since Specialization

Citations

This map shows the geographic impact of Susan G. Kornstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan G. Kornstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan G. Kornstein more than expected).

Fields of papers citing papers by Susan G. Kornstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan G. Kornstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan G. Kornstein. The network helps show where Susan G. Kornstein may publish in the future.

Co-authorship network of co-authors of Susan G. Kornstein

This figure shows the co-authorship network connecting the top 25 collaborators of Susan G. Kornstein. A scholar is included among the top collaborators of Susan G. Kornstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan G. Kornstein. Susan G. Kornstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raskin, Joel, Anita H. Clayton, Susan G. Kornstein, et al.. (2025). A phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder. Current Medical Research and Opinion. 41(9). 1723–1734.

Durgam, Suresh, Willie Earley, Yifan Mo, et al.. (2025). Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial. American Journal of Psychiatry. 182(12). 1072–1082. 1 indexed citations

Cutler, Andrew J., Gregory W. Mattingly, Susan G. Kornstein, et al.. (2023). Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 85(1). 8 indexed citations

Feuerstein, Irwin M., Marjorie Jenkins, Susan G. Kornstein, et al.. (2018). Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium. Journal of Women s Health. 27(10). 1195–1203. 8 indexed citations

Watanabe, Koichiro, Michael E. Thase, Toshiaki Kikuchi, et al.. (2017). Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study. International Clinical Psychopharmacology. 32(5). 271–280. 1 indexed citations

Li, Hua, Ling Lu, Eynav Elgavish Accortt, et al.. (2016). Abstracts from Women's Health 2016: The 24 ^th Annual Congress April 14–17, 2016 Washington, DC. Journal of Women s Health. 25(4). A–1. 1 indexed citations

Clayton, Anita H., Eunhee Hwang, Susan G. Kornstein, et al.. (2015). Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder. International Clinical Psychopharmacology. 30(6). 307–315. 4 indexed citations

Kinser, Patricia A., R. K. Elswick, & Susan G. Kornstein. (2014). Potential Long-Term Effects of a Mind–Body Intervention for Women With Major Depressive Disorder: Sustained Mental Health Improvements With a Pilot Yoga Intervention. Archives of Psychiatric Nursing. 28(6). 377–383. 53 indexed citations

Kornstein, Susan G., Roger S. McIntyre, Michael E. Thase, & Matthieu Boucher. (2014). Desvenlafaxine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy. 15(10). 1449–1463. 13 indexed citations

10.

Kornstein, Susan G., Marisa Toups, A. John Rush, et al.. (2013). Do Menopausal Status and Use of Hormone Therapy Affect Antidepressant Treatment Response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study. Journal of Women s Health. 22(2). 121–131. 27 indexed citations

11.

Bobo, William V., Helen Chen, Madhukar H. Trivedi, et al.. (2011). Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report. Journal of Affective Disorders. 133(3). 467–476. 40 indexed citations

12.

Rush, A. John, Madhukar H. Trivedi, Jonathan W. Stewart, et al.. (2011). Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study. American Journal of Psychiatry. 168(7). 689–701. 275 indexed citations

13.

Thase, Michael E., Alan J. Gelenberg, Susan G. Kornstein, et al.. (2010). Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: Results from the PREVENT study. Journal of Psychiatric Research. 45(3). 412–420. 19 indexed citations

14.

Soares, Cláudio N., Susan G. Kornstein, Michael E. Thase, Qin Jiang, & Christine J. Guico‐Pabia. (2009). Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 70(10). 1365–1371. 33 indexed citations

15.

Kornstein, Susan G., Maurizio Fava, Qin Jiang, & Karen A. Tourian. (2009). Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo.. PubMed. 42(3). 21–35. 5 indexed citations

16.

Foster, Cynthia Ewell, Myrna M. Weissman, Daniel J. Pilowsky, et al.. (2008). Remission of Maternal Depression: Relations to Family Functioning and Youth Internalizing and Externalizing Symptoms. Journal of Clinical Child & Adolescent Psychology. 37(4). 714–724. 56 indexed citations

17.

Kornstein, Susan G., James H. Kocsis, Saeeduddin Ahmed, et al.. (2008). Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study. International Clinical Psychopharmacology. 23(6). 357–363. 13 indexed citations

18.

Thase, Michael E., A. John Rush, Robert H. Howland, et al.. (2002). Double-blind Switch Study of Imipramine or Sertraline Treatment of Antidepressant-Resistant Chronic Depression. Archives of General Psychiatry. 59(3). 233–233. 103 indexed citations

19.

Gelenberg, Alan J., Susan G. Kornstein, Robert H. Howland, et al.. (2001). Sertraline versus imipramine to prevent relapse in chronic depression. Journal of Affective Disorders. 65(1). 27–36. 53 indexed citations

20.

Kornstein, Susan G., Alan F. Schatzberg, Michael E. Thase, et al.. (2000). Gender differences in chronic major and double depression. Journal of Affective Disorders. 60(1). 1–11. 364 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact